Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Nerve Block and PRF for Acute Herpes Zoster Pain
NCT06798662Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of liposomal bupivacaine in postherpetic neuralgia (PHN) (4 arms). Primary endpoint: Numerical Rating Scale at Day 90. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06798662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798662.